PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1317483-8	1992	Interleukin-4 administered to cultured cells from TB mice enhanced O2-, as well as MLR and CTL (P less than 0.01), and decreased TNF release but did not alter PM phi TNF-independent anti-tumor responses (P815).	Terbium	50-52	interleukin 4	Mus musculus	0-13	
1317483-10	1992	These findings indicate the therapeutic potential of IL-4 in the TB host which may function through downregulation of TNF production while potentiating certain T cell-dependent and independent anti-tumor immune mechanisms.	Terbium	65-67	interleukin 4	Mus musculus	53-57	
17365019-9	2007	Of particular interest was the decreased levels of the Th2 cytokine IL-4 in TB-derived samples.	Terbium	76-78	interleukin 4	Mus musculus	68-72